EQT-backed SHL Medical buys Weibel CDS

Terms of the deal were not disclosed. SHL Medical is backed by EQT Partners, which reportedly acquired a 31.1% stake in the business in December 2019 using EQT VIII. The fund was 66% deployed as of August 2019.

SHL Medical, founded in 1989, manufactures drug delivery devices such as autoinjectors, pen injectors and inhaler systems. The Swiss company also has operations in Sweden, Taiwan, the US and China, and employs 4,800 staff.

Says Ralph Howald, chief technology officer at SHL Medical: "The addition of Weibel's talent and range of solutions for high-volume injection will not only add depth to our technical portfolio, but also give us greater reach in the self-injection market."

Company
Founded in 2010 in Waldstatt, Weibel CDS is a medical technology company offering products for drug delivery and packaging. It employs fewer than 50 people, according to LinkedIn.

People
SHL Medical – Ulrich Faessler (CEO); Ralph Howard (chief technology officer).
Weibel CDS – Hans Peter Manser (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Portfolio management
• DACH
• Healthcare
• Switzerland
• Buy-and-build
• Build-up
• healthcare
• EQT